Welcome
Support Centre
24 September 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A Comprehensive Evaluation of the Implementation and Impact of Telecare and Telehealth across Health and Social Care - the Whole System Demonstrator (WSD) Project
ISRCTN ISRCTN43002091
DOI 10.1186/ISRCTN43002091
ClinicalTrials.gov identifier
EudraCT number
Public title A Comprehensive Evaluation of the Implementation and Impact of Telecare and Telehealth across Health and Social Care - the Whole System Demonstrator (WSD) Project
Scientific title
Acronym WSD
Serial number at source 4635
Study hypothesis The care of individuals with long-term conditions (such as heart failure and diabetes) and those who need help from social care services (such as frail older people) is very important. The government wants to improve services for these people, by helping health and social care services to work together more effectively. It is hoped that this will lead to better outcomes, with people able to live at home longer, reducing the risk of ill health and providing more support for informal carers. To make this possible, it is also important that these new services do not increase costs.

The Whole System Demonstrator Project:
In a government initiative known as the Whole System Demonstrator project (WSD), it is planned to help health and social services to work together by introducing new technologies into three pilot sites (Cornwall, Kent and Newham). These technologies fall into two general groups:
1. Telecare packages monitor people in their homes and send alerts when required, e.g., sensors to detect falls
2. Telehealth interventions will allow people to communicate at a distance with their health care professional (e.g. sending blood glucose results)

Evaluation:
Although these technologies have been evaluated, published evaluations have been small and insufficiently rigorous. At present it is not clear whether these new technologies are effective and a good use of public money. We intend to test the value of these technologies using a number of different research methods. To achieve this we are using a randomised controlled trial to compare patients using these new technologies with those who receive usual care. We will also use qualitative studies to examine other issues in more detail.
Lay summary Not provided at time of registration
Ethics approval MREC approved (ref: 08/H1005/4)
Study design Multicentre randomised interventional process of care trial with qualitative component
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Primary Care Research Network for England; Subtopic: Not Assigned; Disease: All Diseases
Participants - inclusion criteria The eligibility criteria for the trial have been broadly determined by the policy focus of the funder, the Department of Health, on people with long term conditions and social care needs. They have been reached through discussions with both the Department of Health and the three participating sites. They have also been derived partly from existing evidence about which populations are mostly likely to benefit from the delivery of telecare and telehealth devices but also maximise reliance on professional judgement about which groups are most likely to benefit.

Detailed inclusion criteria:
Individuals aged 18 years or over fulfilling criteria A and B:

Criteria A:
At least one of three long-term index conditions as defined using Quality and Outcomes Framework (QOF) criteria:
1. Heart failure: diagnosis confirmed by echocardiogram or by specialist assessment
2. Diabetes: those with a diagnosis of Type 1 or Type 2 diabetes and:
2.1. A recorded HbA1c in the previous 15 months
2.2. Excluding those in whom the last HbA1c is 7.4 or less
3. Chronic obstructive pulmonary disease (COPD): diagnosis confirmed by spirometry (COPD is diagnosed if the individual has a forced expiratory volume in one second [FEV1] of less than 70% of predicted normal and has an FEV1/forced vital capacity [FVC] ratio less than 70%)
4. Additional physical co-morbidities may be present; these individuals will still be eligible

Criteria B:
5. At least one unplanned admission to hospital relating to their long term
condition(s)in the previous year, or has had at least one episode of care in the past year from intermediate care services, rapid response services, ambulance services, Accident and Emergency relating to their long term condition
6. Individuals aged 18 years and over with social care needs who would benefit from telecare. They must meet one or more of the following criteria:
6.1. Currently in receipt of, or considered to have a need for night sitting
6.2. Receiving 7 or more hours per week of home care or 3.5 or more hours per week of home care plus a meals service (defined by individual not household)
6.3. Receiving 1 or more days per week of day care
6.4. Have had a fall or who are considered at high risk of falling
6.5. A live-in or nearby informal carer facing difficulties carrying their current burden of responsibilities
6.6. Cognitive impairment/confusion (people fulfilling this criterion who are unable to provide written informed consent and do not have a primary informal caregiver available or an advocate will not be approached to participate in the questionnaire study)

The following definition of an informal carer will be used:
Someone who is seeing and helping their family member, relative or friend at least once a week.
Participants - exclusion criteria General exclusion criteria:
1. Lack of ability to understand English (the devices are not currently tailored to support non-English language speakers)
2. Inability to complete the questionnaire with support from a researcher (applies to questionnaire study only - Themes 2 and 3)

Telehealth exclusion criteria:
3. People with one or more of the three index conditions (above) and cognitive impairment/confusion but insufficient informal caregiver support available to enable regular readings to be taken using telehealth equipment. This group will still be eligible to receive telecare.
4. Individuals without an appropriate power supply or telephone line in their place of residence (Telehealth requires an appropriate power supply or telephone line so if this is not available it cannot be installed)
5. Telehealth already installed (this exclusion criteria is likely to only apply to the Kent site where some pilot work has already been undertaken with telehealth equipment - individuals who already have telehealth equipment will need to be excluded to reduce learning effects)

Telecare exclusion criteria:
6. Telecare already installed (excluding pendant alarms)
Anticipated start date 01/05/2008
Anticipated end date 30/09/2009
Status of trial Completed
Patient information material
Target number of participants Planned sample size: 6000; UK sample size: 6000
Interventions 1. Telecare assistive devices: Telecare assistive devices and support for individuals receiving social care, controls will receive usual care
2. Telehealth assistive devices: Telehealth assistive devices and support for individuals with long term condition (heart failure, chronic obstructive pulmonary disease [COPD] and diabetes)
3. Control: controls will receive usual care
Primary outcome measure(s) 1. 36-item Short Form Health Survey (SF-36)
2. EuroQoL questionnaire (EQ-5D)
3. Generic heart-failure, diabetes and COPD quality of life (QoL) questionnaires
4. Center for Epidemiologic Studies Depression Scale (CES-D)
5. 6-Item Short-Form of the State Scale of the Spielberger State Trait Anxiety Inventory (STAI-6)

All measured at 3 and 12 months.
Secondary outcome measure(s) No secondary outcome measures
Sources of funding Department of Health (UK)
Trial website
Publications 2011 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/21819569
2012 secondary care and mortality results in: http://www.ncbi.nlm.nih.gov/pubmed/22723612
2013 cost-effectiveness in: http://www.ncbi.nlm.nih.gov/pubmed/23520339
2013 health and social care services results in: http://www.ncbi.nlm.nih.gov/pubmed/23443509
2013 general practice contacts results in: http://www.ncbi.nlm.nih.gov/pubmed/24099334
2013 quality of life results in: http://www.ncbi.nlm.nih.gov/pubmed/24333802
2014 cost-effectiveness results in: http://www.ncbi.nlm.nih.gov/pubmed/24950690
2014 type 2 diabetes results in: http://www.ncbi.nlm.nih.gov/pubmed/25100190
Contact name Mr  Shashivadan  Hirani
  Address Charles Bell House
67-73 Riding House Street
  City/town London
  Zip/Postcode W1W 7EJ
  Country United Kingdom
  Email s.hirani@ucl.ac.uk
Sponsor Department of Health (UK)
  Address Policy Research Programme
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NS
  Country United Kingdom
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 28/05/2010
Last edited 08/08/2014
Date ISRCTN assigned 28/05/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.